Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment.
Chen Z, Simon-Molas H, Cretenet G, Valle-Argos B, Smith LD, Forconi F, Schomakers BV, van Weeghel M, Bryant DJ, van Bruggen JAC, Peters FS, Rathmell JC, van der Windt GJW, Kater AP, Packham G, Eldering E. Chen Z, et al. Among authors: van der windt gjw. Blood. 2022 Aug 11;140(6):630-643. doi: 10.1182/blood.2021013990. Blood. 2022. PMID: 35486832 Free PMC article.
PD-L1 blockade: rejuvenating T cells in CLL.
Kater AP, van der Windt GJ. Kater AP, et al. Blood. 2015 Jul 9;126(2):126-8. doi: 10.1182/blood-2015-05-638338. Blood. 2015. PMID: 26160184 Free article. No abstract available.
Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy.
van Bruggen JAC, Martens AWJ, Fraietta JA, Hofland T, Tonino SH, Eldering E, Levin MD, Siska PJ, Endstra S, Rathmell JC, June CH, Porter DL, Melenhorst JJ, Kater AP, van der Windt GJW. van Bruggen JAC, et al. Among authors: van der windt gjw. Blood. 2019 Jul 4;134(1):44-58. doi: 10.1182/blood.2018885863. Epub 2019 May 10. Blood. 2019. PMID: 31076448 Free PMC article.
CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells.
Martens AWJ, Janssen SR, Derks IAM, Adams Iii HC, Izhak L, van Kampen R, Tonino SH, Eldering E, van der Windt GJW, Kater AP. Martens AWJ, et al. Among authors: van der windt gjw. J Immunother Cancer. 2020 Jun;8(1):e000218. doi: 10.1136/jitc-2019-000218. J Immunother Cancer. 2020. PMID: 32581054 Free PMC article.
Chronic lymphocytic leukemia presence impairs antigen-specific CD8+ T-cell responses through epigenetic reprogramming towards short-lived effectors.
Martens AWJ, Kavazović I, Krapić M, Pack SM, Arens R, Jongejan A, Moerland PD, Eldering E, van der Windt GJW, Wensveen FM, Peters FS, Kater AP. Martens AWJ, et al. Among authors: van der windt gjw. Leukemia. 2023 Mar;37(3):606-616. doi: 10.1038/s41375-023-01817-z. Epub 2023 Jan 19. Leukemia. 2023. PMID: 36658390 Free PMC article.
CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability.
van der Windt GJ, O'Sullivan D, Everts B, Huang SC, Buck MD, Curtis JD, Chang CH, Smith AM, Ai T, Faubert B, Jones RG, Pearce EJ, Pearce EL. van der Windt GJ, et al. Proc Natl Acad Sci U S A. 2013 Aug 27;110(35):14336-41. doi: 10.1073/pnas.1221740110. Epub 2013 Aug 12. Proc Natl Acad Sci U S A. 2013. PMID: 23940348 Free PMC article.
40 results